TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PharmaLex Sweden AB
Closing information (x1000 NOK)
| Closing information | 2023/09 | 2022/12 | 2021/12 |
| Turnover |
27,178
|
25,329
|
16,923 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
402
|
2,560
|
1,165 |
| EBITDA |
408
|
2,576
|
1,182 |
| Total assets |
9,739
|
8,790
|
6,925 |
| Current assets |
9,699
|
8,741
|
6,859 |
| Current liabilities |
7,162
|
5,170
|
5,281 |
| Equity capital |
2,577
|
3,620
|
1,644 |
| - share capital |
98
|
95
|
98 |
| Employees (average) |
12
|
11
|
9 |
Financial ratios
| Fiscal year | 2023/09 | 2022/12 | 2021/12 |
| Solvency |
26.5%
|
41.2%
|
23.7% |
| Turnover per employee |
2,265
|
2,303
|
1,880 |
| Profit as a percentage of turnover |
1.5%
|
10.1%
|
6.9% |
| Return on assets (ROA) |
4.1%
|
29.1%
|
16.8% |
| Current ratio |
135.4%
|
169.1%
|
129.9% |
| Return on equity (ROE) |
15.6%
|
70.7%
|
70.9% |
| Change turnover |
930
|
8,914
|
3,352 |
| Change turnover % |
4%
|
54%
|
25% |
| Chg. No. of employees |
1
|
2
|
1 |
| Chg. No. of employees % |
9%
|
22%
|
13% |
Total value of public sale
| Fiscal year | 2023/09 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.